Enhancement by dimethyl myleran of donor type chimerism in murine recipients of bone marrow allografts.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Blood

• Publication date

  1989-05-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD.V73.7.2025.2025PMID 2653469
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Haematopoiesis in busulphan-treated mice. A comparison between two different stem cell assays.

  2009cited by this paper
• Augmentation of donor bone marrow engraftment in histoincompatible murine recipients by granulocyte/macrophage colony-stimulating factor.

  1988cited by this paper
• Transient engraftment of T cell-depleted allogeneic bone marrow in mice improves survival rate following lethal irradiation.

  1988cited by this paper
• Marrow repopulation in mice treated with busulphan or isopropyl methane sulphonate and bone marrow

  1987cited by this paper
• Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias.

  1987cited by this paper
• The role of natural killer cells in resistance to allogeneic and parental hybrid resistance.

  1987cited by this paper
• Abrogation of bone marrow allograft resistance in mice by increased total body irradiation correlates with eradication of host clonable T cells and alloreactive cytotoxic precursors.

  1987cited by this paper
• Graft rejection and graft-versus-host disease: mirror images.

  1986cited by this paper
• Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs

  1986cited by this paper
• Demonstration of clonable alloreactive host T cells in a primate model for bone marrow transplantation.

  1986cited by this paper
• Monoclonal antibodies to promote marrow engraftment and tissue graft tolerance

  1986cited by this paper
• Recipient immune-competent T lymphocytes can survive intensive conditioning for bone marrow transplantation.

  1986cited by this paper
• Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs.

  1986cited by this paper
• Monoclonal antibodies for the prevention of graft-versus-host disease and marrow graft rejection. The depletion of T cell subsets in vitro and in vivo.

  1986cited by this paper
• Bone marrow from cadaver donors for transplantation.

  1985cited by this paper
• Bone marrow engraftment efficiency is enhanced by competitive inhibition of the hepatic asialoglycoprotein receptor.

  1985cited by this paper
• Strain difference in the radiosensitivity of immunocompetent cells and its influence on the residual host-vs-graft reaction in lethally irradiated mice grafted with semiallogeneic bone marrow.

  1985cited by this paper
• Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts.

  1985cited by this paper
• A correlation between conditioning and engraftment in recipients of MHC-mismatched T cell-depleted murine bone marrow transplants.

  1985cited by this paper
• Bone marrow from cadaver donors for transplantation

  1985cited by this paper
• Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

  1985cited by this paper
• Elimination of graft-versus-host disease by in-vitro depletion of alloreactive lymphocytes with a monoclonal rat anti-human lymphocyte antibody (CAMPATH-1).

  1984cited by this paper
• Transplantation for severe combined immunodeficiency with HLA-A,B,D,DR incompatible parental marrow cells fractionated by soybean agglutinin and sheep red blood cells.

  1983cited by this paper
• Allogeneic Bone‐Marrow Transplantation

  1983cited by this paper
• Reconstitution after transplantation with T-lymphocyte-depleted HLA haplotype-mismatched bone marrow for severe combined immunodeficiency.

  1982cited by this paper
• BONE MARROW TRANSPLANTATION ACROSS MAJOR HISTOCOMPATIBILITY BARRIERS IN MICE EFFECT OF ELIMINATION OF T CELLS FROM DONOR GRAFTS BY TREATMENT WITH MONOCLONAL THY‐1.2 PLUS COMPLEMENT OR ANTIBODY ALONE

  1981cited by this paper
• Humoral and cell-mediated immune responses in fully allogeneic bone marrow chimera in mice

  1980cited by this paper
• Rejection of marrow from DLA-identical canine littermates given transfusions before grafting: antigens involved are expressed on leukocytes and skin epithelial cells but not on platelets and red blood cells.

  1979cited by this paper
• Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins.

  1978cited by this paper
• Loss of immunoreactivity in long-term bone marrow culture

  1978cited by this paper
• Preceding transfusions and marrow graft rejection in dogs and man.

  1976cited by this paper
• Separation of mouse thymocytes into two subpopulations by the use of peanut agglutinin.

  1976cited by this paper
• Toxicologic and marrow transplantation studies in rhesus monkeys given dimethyl myleran.

  1975cited by this paper
• A primary stem cell lesion in experimental chronic hypoplastic marrow failure.

  1975cited by this paper
• Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras

  1975cited by this paper
• Immunologic, toxicologic and marrow transplantation studies in dogs given dimethyl myleran.

  1974cited by this paper
• Marrow transplantation in the busulfan-treated rat: preclinical model of aplastic anemia.

  1974cited by this paper
• Effect of Isopropyl Methane Sulphonate (IMS) on Haemopoietic Colony‐Forming Cells

  1973cited by this paper
• PECULIAR IMMUNOBIOLOGY OF BONE MARROW ALLOGRAFTS

  1971cited by this paper
• Allogeneic bone marrow transplantation after elimination of immunocompetent cells by means of density gradient centrifugation.

  1971cited by this paper
• Allogeneic bone marrow transplantation after elimination of immunocompetent cells by means of density gradient centrifugation.

  1971cited by this paper
• Cloning of syngeneic hematopoietic cells in the spleens of mice and rats pretreated with cytotoxic drugs.

  1968cited by this paper

• The rationale behind grafting haploidentical hematopoietic stem cells

  2024cites this paper
• Engraftment, Graft Rejection, and Graft Failure

  2019cites this paper
• Veto cells for safer nonmyeloablative haploidentical HSCT and CAR T cell therapy.

  2019cites this paper
• 2 Donor Sources and Donor Selection for Hematopoietic Cell Transplant

  2019cites this paper
• Toward Safer CD34+ Megadose T-Cell-Depleted Transplants Following Reduced Intensity and Nonmyeloablative Conditioning Regimens

  2018cites this paper
• Historical Perspective and Current Trends in Haploidentical Transplantation

  2018cites this paper
• In-vivo or ex-vivo T cell depletion or both to prevent graft-versus-host disease after hematopoietic stem cell transplantation

  2017influential citation
• NK Cell and CD4+FoxP3+ Regulatory T Cell Based Therapies for Hematopoietic Stem Cell Engraftment

  2016cites this paper
• Modern approaches to HLA-haploidentical blood or marrow transplantation.

  2016cites this paper
• Haploidentical transplants using ex vivo T-cell depletion.

  2016cites this paper
• The evolution of T‐cell depletion in haploidentical stem‐cell transplantation

  2016cites this paper
• Modern approaches to HLA-haploidentical blood or marrow transplantation

  2016cites this paper
• The Experimental Basis for Hematopoietic Cell Transplantation for Autoimmune Diseases

  2016cites this paper
• Haploidentical hematopoietic stem cell transplantation: state of art

  2015cites this paper
• Cell Manipulation in Pediatric Haploidentical Stem Cell Transplantation: State of the Art

  2015cites this paper
• Next generation HLA-haploidentical HSCT

  2015cites this paper
• The role of donor-derived veto cells in nonmyeloablative haploidentical HSCT

  2015cites this paper
• Donor Sources and Donor Selection for Hematopoietic Cell Transplant

  2014cites this paper
• Megadose stem cell administration as a route to mixed chimerism.

  2014cites this paper
• Immune Rejection: The Immune Biology of Allogeneic Hematopoietic Stem Cell Transplantation (from Mice to Humans)

  2013cites this paper
• Haploidentical hematopoietic transplantation: current status and future perspectives.

  2011cites this paper
• Induction of transplantation tolerance in haploidenical transplantation under reduced intensity conditioning: the role of ex-vivo generated donor CD8+ T cells with central memory phenotype.

  2011cites this paper
• spleen colony-forming activity Characterization of mouse lymphohematopoietic stem cells lacking

  2011cites this paper
• TCR-Independent Killing of B Cell Malignancies by Anti–Third-Party CTLs: The Critical Role of MHC–CD8 Engagement

  2011cites this paper
• Crossing hla barriers by “megadose” stem cell transplants

  2010cites this paper
• Hematopoietic Cell Transplantation from Partially HLA-Mismatched (HLA-Haploidentical) Related Donors

  2010cites this paper
• Induction of tolerance in organ recipients by hematopoietic stem cell transplantation.

  2009cites this paper
• Haploidentical haematopoietic stem cell transplantation for acute leukaemia in adults: experience in Europe and the United States

  2008cites this paper
• From 'megadose' haploidentical hematopoietic stem cell transplants in acute leukemia to tolerance induction in organ transplantation.

  2008cites this paper
• The haploidentical option for high-risk haematological malignancies.

  2008cites this paper
• Combined neonatal blood transplants in a parent‐to‐F1 mouse model: Improved survival rates and stable long‐term engraftment

  2007cites this paper
• Hematopoietic stem cell transplantation from alternative donors for high-risk acute leukemia: the haploidentical option.

  2007cites this paper
• Key factors in experimental mouse hematopoietic stem cell transplantation

  2006cites this paper
• Overcoming T cell-mediated rejection of bone marrow allografts by T-regulatory cells: synergism with veto cells and rapamycin.

  2006cites this paper
• The role of veto cells in bone marrow transplantation

  2006cites this paper
• Hematopoietic Stem Cell Transplantation from Human Leukocyte Antigen Haploidentical Donor

  2006cites this paper
• Hematopoietic Stem Cell Transplantation across Major Genetic Barriers: Tolerance Induction by Megadose CD34 Cells and Other Veto Cells

  2005cites this paper
• Hematopoietic stem cell transplantation from alternative sources in adults with high-risk acute leukemia.

  2004cites this paper
• Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases

  2004influential citation
• Crossing the HLA barriers.

  2004cites this paper
• Anti-third-party veto CTLs overcome rejection of hematopoietic allografts: synergism with rapamycin and BM cell dose.

  2003cites this paper
• The role of haploidentical stem cell transplantation in the management of children with haematological disorders

  2003cites this paper
• Hematopoietic stem cell transplantation across major genetic barriers: tolerance induction by megadose CD34 cells and other veto cells.

  2003cites this paper
• Haploidentical Stem Cell Transplantation

  2003cites this paper
• The Role of T Cell Depletion in Bone Marrow Transplantation

  2003cites this paper
• Hematopoietic stem cell transplantation across major genetic barriers

  2003cites this paper
• Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation.

  2003cites this paper
• Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells.

  2002cites this paper
• Impact of CD34 Cell Dose on Acute Graft Versus Host Disease After Allogeneic Bone Marrow Stem Cell Transplantation

  2002cites this paper
• Megadose of hematopoietic stem cells for haploidentical transplants

  2002cites this paper
• Transplants across human leukocyte antigen barriers.

  2002cites this paper
• Hematopoietic stem cell transplantation from full-haplotype mismatched donors.

  2002cites this paper
• Mixed peripheral blood stem cell transplantation for autoimmune disease in BXSB/MpJ mice.

  2002cites this paper
• Bone marrow transplantation across major genetic barriers: the role of megadose stem cells and nonalloreactive donor anti-third party CTLS.

  2001cites this paper
• Genetically haploidentical stem cell transplantation for acute leukemia

  2001cites this paper
• New method for thyroid transplantation across major histocompatibility complex barriers using allogeneic bone marrow transplantation.

  2001cites this paper
• A New Method for Tolerance Induction: Busulfan Administration Followed by Intravenous Injection of Neuraminidase‐Treated Donor Bone Marrow

  2001cites this paper
• The current status of T-cell depleted allogeneic stem-cell transplants in adult patients with AML.

  2001cites this paper
• The Role of Total Body Irradiation in the Conditioning of Patients Receiving Haploidentical Stem Cell Transplantation

  2001cites this paper
• Allogeneic transplantation across the HLA barriers.

  2001cites this paper
• Haploidentical stem cell transplantation in leukemia.

  2001cites this paper
• Immunogenicity of Ly5 (CD45)‐Antigens Hampers Long‐Term Engraftment Following Minimal Conditioning in a Murine Bone Marrow Transplantation Model

  2001cites this paper
• Anti-third party CD8+ CTLs as potent veto cells: coexpression of CD8 and FasL is a prerequisite.

  2000cites this paper
• Transplantation tolerance induced by "mega dose" CD34+ cell transplants.

  2000cites this paper
• Tolerance induction by 'megadose' transplants of CD34+ stem cells: a new option for leukemia patients without an HLA-matched donor.

  2000cites this paper
• Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: synergism with non-alloreactive (host x donor)F(1) T cells.

  1999cites this paper
• The Role of Megadose CD34+ Progenitor Cells in the Treatment of Leukemia Patients without a Matched Donor and in Tolerance Induction for Organ Transplantation

  1999cites this paper
• Stem cell escalation enables HLA-disparate haematopoietic transplants in leukaemia patients.

  1999cites this paper
• Allogeneic hematopoietic stem‐cell engraftment and graft failure

  1999cites this paper
• Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen.

  1999cites this paper
• Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models.

  1999cites this paper
• Induction of Donor-Type Chimerism and Transplantation Tolerance Across Major Histocompatibility Barriers in Sublethally Irradiated Mice by Sca-1+Lin− Bone Marrow Progenitor Cells: Synergism With Non-Alloreactive (Host × Donor)F1 T Cells

  1999cites this paper
• Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

  1998cites this paper
• An alternative conditioning regimen for induction of specific skin graft tolerance across full major histocompatibility complex barriers.

  1998cites this paper
• Clinical use of allogeneic hematopoietic stem cells from sources other than bone marrow.

  1998cites this paper
• TOLERANCE INDUCTION BY "MEGADOSE" HEMATOPOIETIC TRANSPLANTS

  1998cites this paper
• Requirement of Major Histocompatibility Complex‐Compatible Microenvironment for Spleen Colony Formation (CFU‐S on day 12 but not on day 8)

  1997cites this paper
• T Cells, Graft-versus-Host Disease and Graft-versus-Leukemia: Innovative Approaches for Blood and Marrow Transplantation

  1996cites this paper
• T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.

  1996cites this paper
• Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity.

  1996cites this paper
• Alloantigen Presenting Function of Normal Human CD34+ Hematopoietic Cells

  1996cites this paper
• Alloantigen presenting function of normal human CD34+ hematopoietic cells.

  1996cites this paper
• FUTURE GOALS FOR THERAPEUTIC MONOCLONAL ANTIBODIES

  1995cites this paper
• Bone marrow transplantation across HLA barriers by increasing the number of transplanted cells.

  1995cites this paper
• Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice

  1995cites this paper
• Optimizing the Composition of Bone Marrow for Allogeneic Transplantation

  1995cites this paper
• Hematopoietic stem cell transplantation for cancer therapy.

  1995cites this paper
• Influence of donor lymphocytes on the incidence of primary graft failure after allogeneic bone marrow transplatition in a murine model

  1994cites this paper
• What can be done to prevent graft versus host disease?

  1994cites this paper
• Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.

  1994cites this paper
• Attenuation of graft-versus-host disease and graft rejection by ex vivo immunotoxin elimination of alloreactive T cells in an H-2 haplotype disparate mouse combination.

  1994cites this paper
• Relationships between ablation of distinct haematopoietic cell subsets and the development of donor bone marrow engraftment following recipient pretreatment with different alkylating drugs.

  1994cites this paper
• Successful engraftment of T-cell-depleted haploidentical "three-loci" incompatible transplants in leukemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum.

  1994cites this paper
• The influence of graft-versus-host reactivity, lymphocyte depletion, and cell dose on allogeneic bone marrow engraftment.

  1993cites this paper
• Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.

  1993cites this paper
• Donor CD8 cells prevent allogeneic marrow graft rejection in mice: potential implications for marrow transplantation in humans

  1993influential citation
• T-Cell Depletion for Allogeneic Bone Marrow Transplantation: Impact on Graft-Versus-Host Disease, Engraftment, and Graft-Versus-Leukemia

  1993cites this paper
• Allogeneic bone marrow transplantation following busulfan and 90 mg/kg of cyclophosphamide.

  1993cites this paper
• Is there any future for T-cell depleted bone marrow transplantation in chronic myeloid leukaemia?

  1993cites this paper
• Enhancement of BM allografting from C57BL/6 'nude' mice into C3H/HeJ recipients by tolerized T cells from (C57BL/6-->C3H/HeJ) and (C3H/HeJ-->C57BL/6) chimeras.

  1993cites this paper